Scholars Central

Conference abstract

Pharmacometrics in the translational pharmacology paradigm

Authors: Sujit Nair

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Exciting synergy between disciplines of pharmacokinetics, pharmacodynamics, pharmacogenomics, biostatistics and clinical pharmacology has translated into increased reliance on modeling and simulation strategies for better informing ?go/no-go? decisions, candidate optimization and biomarker validation in the discovery pipeline in pharmaceutical industry. With increasing practice of pharmacometrics in both the drug development and regulatory domains, we are moving away from empirical descriptions of exposure-response relationships towards more sophisticated pharmacometric models which we will exemplify and dissect. Strengths of model-based drug development and potential oversights will be discussed. With pharmacometrics fast occupying centre-stage in the translational medicine paradigm, unmet needs in modeling and simulation as well as future implications for personalized medicine will also be discussed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical & Experimental Pharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Pharmacology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sujit Nair”